Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: A functional genomics approach

Gut

Volumn 57, Issue 8, 2008, Pages 1090-1096

  Wong, H L ^a   Koh, W P ^b   Probst Hensch, N M ^c   Van Den Berg, D ^d   Yu, M C ^e   Ingles, Sue A ^d  

^a DDHS   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER INCIDENCE; CANCER RISK; CHINESE; COLON CARCINOGENESIS; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FEMALE; FUNCTIONAL GENOMICS; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RECTUM CANCER; REGULATOR GENE; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BODY MASS INDEX; COLORECTAL NEOPLASMS; CONSERVED SEQUENCE; EFFECT MODIFIERS (EPIDEMIOLOGY); ENERGY METABOLISM; EVOLUTION, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LIFE STYLE; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 48249088401     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.140855     Document Type: Article

References (59)

1. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
2. Komninou D, Ayonote A, Richie JP Jr, et al. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 2003;228:396-405.
3. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-95.
4. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
5. Heald A, Sharma R, Anderson S, et al. Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake. Public Health Nutr 2005;8:620-7.
6. Lahm H, Suardet L, Laurent PL, et al. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br J Cancer 1992;65:341-6.
7. Whithead RH, Nice EC, Lloyd CJ, et al. Detection of colonic growth factors using a human colonic carcinoma cell line (LIM1215). Int J Cancer 1990;46:858-63.
8. Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169-73.
9. Hague A, Hicks DJ, Bracey TS, et al. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis. Br J Cancer 1997;75:960-8.
10. Remacle-Bonnet MM, Garrouste FL, Heller S, et al. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha- induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 2000;60:2007-17.
11. Guo YS, Jin GF, Houston CW, et al. Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cells. J Cell Physiol 1998;175:141-8.
12. Sekharam M, Zhao H, Sun M, et al. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res 2003;63:7708-16.
13. Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205-11.
14. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989;80:51-8.
15. Reinmuth N, Fan F, Liu W, et al. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 2002;82:1377-89.
16. Wu Y, Yakar S, Zhao L, et al. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 2002;62:1030-5.
17. Hirose Y, Hata K, Kuno T, et al. Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Carcinogenesis 2004;25:821-5.
18. Hassan AB, Howell JA. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res 2000;60:1070-6.
19. Bjorndahl M, Cao R, Nissen LJ, et al. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A 2005;102:15593-8.
20. D'Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci U S A 1984;81:935-9.
21. Platz EA, Pollak MN, Rimm EB, et al. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 1999;8:1107-10.
22. Girgis R, Abrams SA, Castracane VD, et al. Ethnic differences in androgens, IGF-I and body fat in healthy prepubertal girls. J Pediatr Endocrinol Metab 2000;13:497-503.
23. DeLellis K, Ingles S, Kolonel L, et al. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 2003;88:277-82.
24. Cruickshank JK, Heald AH, Anderson S, et al. Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 2001;154:504-13.
25. Pastinen T, Hudson TJ. Cis-acting regulatory variation in the human genome. Science 2004;306:647-50.
26. Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.
27. Nomura AMSG, Lee J, Pollak MN. Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men. Am J Epidemiol 2003;158:423-31.
28. Giovannucci E, Pollak MN, Platz EA, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000;9:345-9.
29. Palmqvist R, Hallmans G, Rinaldi S, et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002;50:642-6.
30. Probst-Hensch NM, Yuan JM, Stanczyk FZ, et al. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 2001;85:1695-9.
31. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
32. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
33. Harrela M, Koistinen H, Kaprio J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996;98:2612-5.
34. Kao PC, Matheny AP Jr, Lang CA. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab 1994;78:310-2.
35. Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
36. Wong HL, Delellis K, Probst-Hensch N, et al. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 2005;14:144-51.
37. Seow A, Yuan JM, Koh WP, et al. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006;98:135-8.
38. Hankin JH, Stram DO, Arakawa K, et al. Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 2001;39:187-95.
39. Chia KS, Lee HP, Shanmugaratnam K, eds. Cancer incidence in Singapore 1993-1997. Singapore: Singapore Cancer Registry. Report No.5, 2000.
40. Schwartz S, Kent WJ, Smit A, et al. Human-mouse alignments with BLASTZ. Genome Res 2003;13:103-7.
41. Ovcharenko I, Nobrega MA, Loots GG, et al. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucl Acids Res 2004;32:W280-6.
42. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucl Acids Res 1993;21:3761-6.
43. Breslow NE, Day NE. Statistical methods in cancer research. Lyon: IARC, 1980.
44. Probst-Hensch NM, Wang H, Goh VH, et al. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 2003;12:739-46.
45. Li CC. First course in population genetics. CA: The Boxwood Press, Pacific Grove, 1976.
46. Chiano MN, Clayton DG. Genotypic relative risks under ordered restriction. Genetic Epidemiol 1998;15:135-46.
47. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988;120:849-52.
48. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control, AC 1974;19:716-23.
49. Akaike H. Canonical correlation analysis of time series and the use of an information criterion. In: Mehra RKaLD, ed. System identification: advances and case studies. New York: Academic Press, 1976: 52-107.
50. Slattery ML, Murtaugh M, Caan B, et al. Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer 2005;115:148-54.
51. Morimoto LM, Newcomb PA, White E, et al. Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1204-11.
52. Slattery ML, Samowitz W, Curtin K, et al. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1206-14.
53. Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucl Acids Res 2007;35L:D760-5.
54. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62.
55. Iida K, Rosen CJ, Ackert-Bicknell C, et al. Genetic differences in the IGF-I gene among inbred strains of mice with different serum IGF-I levels. J Endocrinol 2005;186:481-9.
56. Cavalli-Sforza LL. The Chinese human genome diversity project. Proc Natl Acad Sci U S A 1998;95:11501-3.
57. Chu JY, Huang W, Kuang SQ, et al. Genetic relationship of populations in China. Proc Natl Acad Sci U S A 1998;95:11763-8.
58. Deng HW, Chen WM, Recker RR. Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkage-disequilibrium methods for localizing genes underlying complex traits. Genetics 2001;157:885-97.
59. Spielman RS, Bastone LA, Burdick JT, et al. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007;39:226-31.